Sort
48,018 grants matching “immunotherapy”
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
$817,028Leslie S Kean · Emory University · R01 · FY2012 · HL
Immune and transcriptomic biomarkers of progressive oral premalignant lesions
$816,981Fatemeh Momen Heravi · University Of California, San Francisco · U01 · FY2025 · DE
Strategies for Therapeutic Cancer Vaccine Clinical Trials
$816,925Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Fluorescent nanofoldamers for multiplex flow cytometry
$816,870Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2023 · GM
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
$816,856Joren C Madsen · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · AI
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE
$816,746Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2017 · AI
Immune reconstitution following autologous and allogeneic stem cell transplant
$816,678Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
SOUTHEAST PEDIATRIC AIDS CLINICAL TRIALS UNIT
$816,559University Of Alabama At Birmingham · U01 · FY2000 · AI
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
$816,338Louis J. Picker · Oregon Health & Science University · P01 · FY2025 · AI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation
$816,219Willem Mulder · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Cancer Center Support Grant - Core Consolidation Supplement
$816,000Mark A Israel · Dartmouth College · P30 · FY2010 · CA
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
$815,928Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells
$815,880Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential
$815,764Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2025 · EB
Immunotherapy of inflammation, autoimmune disease and cancer
$815,669Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
The role of the innate immune system on Treg reprogramming in human autoimmune di
$815,616David A. Hafler · Yale University · U01 · FY2012 · AI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation
$815,612Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · HL
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
$815,509Justin M Balko · Vanderbilt University Medical Center · R01 · FY2023 · HL
Determinants of response to cancer immunotherapy
$815,497Lawrence Fong · University Of California, San Francisco · R35 · FY2021 · CA
Tulane/LSU Pediatric AIDS Clinical Trials Unit
$815,476Tulane University Of Louisiana · U01 · FY2002 · AI
Immune epigenetic biomarkers of survival in glioma epidemiology
$815,423John K. Wiencke · University Of California, San Francisco · R01 · FY2018 · CA
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
$815,317Peng Wu · Scripps Research Institute, The · R01 · FY2021 · AI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation
$815,005Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · HL
Image-based models of tumor-immune dynamics in glioblastoma
$814,918Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2022 · CA
3BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoir
$814,897Marina Caskey · Rockefeller University · U01 · FY2020 · AI